CVS HEALTH Corp Purchases Shares of 20,000 Vanguard FTSE Developed Markets ETF $VEA

CVS HEALTH Corp purchased a new position in shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEAFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 20,000 shares of the company’s stock, valued at approximately $1,282,000. Vanguard FTSE Developed Markets ETF accounts for approximately 0.6% of CVS HEALTH Corp’s investment portfolio, making the stock its 19th biggest holding.

Several other hedge funds have also made changes to their positions in VEA. Cherry Creek Investment Advisors Inc. increased its stake in Vanguard FTSE Developed Markets ETF by 1.6% in the first quarter. Cherry Creek Investment Advisors Inc. now owns 9,836 shares of the company’s stock valued at $630,000 after purchasing an additional 151 shares during the last quarter. Mascagni Wealth Management Inc. lifted its position in Vanguard FTSE Developed Markets ETF by 2.1% during the fourth quarter. Mascagni Wealth Management Inc. now owns 7,231 shares of the company’s stock worth $452,000 after buying an additional 152 shares during the period. Ironwood Investment Counsel LLC boosted its stake in Vanguard FTSE Developed Markets ETF by 0.4% in the 1st quarter. Ironwood Investment Counsel LLC now owns 39,675 shares of the company’s stock worth $2,542,000 after buying an additional 153 shares during the last quarter. TL Private Wealth boosted its stake in Vanguard FTSE Developed Markets ETF by 1.7% in the 4th quarter. TL Private Wealth now owns 9,396 shares of the company’s stock worth $606,000 after buying an additional 155 shares during the last quarter. Finally, River Wealth Advisors LLC boosted its stake in Vanguard FTSE Developed Markets ETF by 1.3% in the 4th quarter. River Wealth Advisors LLC now owns 12,143 shares of the company’s stock worth $759,000 after buying an additional 161 shares during the last quarter.

Vanguard FTSE Developed Markets ETF Price Performance

VEA opened at $69.23 on Tuesday. Vanguard FTSE Developed Markets ETF has a 12 month low of $55.68 and a 12 month high of $73.23. The business has a 50-day moving average of $70.81 and a two-hundred day moving average of $68.04. The stock has a market capitalization of $224.30 billion, a price-to-earnings ratio of 16.34 and a beta of 0.83.

Vanguard FTSE Developed Markets ETF Profile

(Free Report)

The Vanguard Developed Markets Index Fund (VEA) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market-cap weighted index of large-, mid- and small-cap stocks from developed markets outside the US. VEA was launched on Jul 20, 2007 and is managed by Vanguard.

Recommended Stories

Want to see what other hedge funds are holding VEA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard FTSE Developed Markets ETF (NYSEARCA:VEAFree Report).

Institutional Ownership by Quarter for Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)

Receive News & Ratings for Vanguard FTSE Developed Markets ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard FTSE Developed Markets ETF and related companies with MarketBeat.com's FREE daily email newsletter.